Q32 Bio Inc. logo

Q32 Bio Inc.

QTTB | NASDAQ
Chart Builder DCF Calculator
$10.47
-$0.07 (-0.66%)
At close: Sep 21, 2026, 4:00 PM ET
$10.98
+$0.51 (+4.85%)
Pre-market: Sep 22, 2026, 7:55 AM ET
Fiscal Year
Period Ending
FY 2025
Dec 30, 2025
FY 2024
Dec 30, 2024
FY 2023
Dec 30, 2023
FY 2022
Dec 30, 2022
FY 2021
Dec 30, 2021
FY 2020
Dec 30, 2020
Revenue
53.74M n/a -6.65M 6.65M n/a 2.7M
Cost of Revenue
n/a n/a n/a n/a n/a n/a
Gross Profit
53.74M n/a -6.65M 6.65M n/a 2.7M
Operating Income
16.9M -66.1M -48.26M -39.23M -36.69M -130.26M
Interest Income
2.2M 3.9M n/a n/a n/a 1.57M
Pretax Income
29.82M -47.71M -53.43M -42.75M -37.02M -128.69M
Net Income
29.82M -47.73M -53.74M -42.81M -37.56M -128.69M
Selling & General & Admin
17.68M 17.96M 9.88M 10.06M 6.76M 23.67M
Research & Development
19.16M 48.14M 31.73M 35.81M 29.93M 100.39M
Other Expenses
n/a n/a n/a n/a n/a n/a
Operating Expenses
36.84M 66.1M 41.6M 45.88M 36.69M 124.06M
Interest Expense
1.1M 1.1M n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a
Cost & Expenses
36.84M 66.1M 41.6M 45.88M 36.69M 132.97M
Income Tax Expense
n/a 21K 318K 62K 547K n/a
Shares Outstanding (Basic)
12.3M 9.32M 11.93M 11.93M 11.93M 2.55M
Shares Outstanding (Diluted)
12.31M 9.66M 11.93M 11.93M 11.93M 2.55M
EPS (Basic)
2.42 -5.12 -4.51 -3.59 -3.15 -50.46
EPS (Diluted)
2.42 -6.58 -4.51 -3.59 -3.15 -50.46
EBITDA
31.31M -44.5M -47.76M -38.86M -36.65M -119.79M
EBIT
30.92M -44.99M -48.26M -39.23M -36.69M -128.69M
Depreciation & Amortization
391K 487K 499K 370K 47K 8.9M

© 2026 bestshares.com. All rights reserved.